Elinogrel

CAS No. 936500-94-6

Elinogrel( PRT060128 )

Catalog No. M26193 CAS No. 936500-94-6

Elinogrel is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 187 Get Quote
25MG 376 Get Quote
50MG 570 Get Quote
100MG 795 Get Quote
500MG 1647 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Elinogrel
  • Note
    Research use only, not for human use.
  • Brief Description
    Elinogrel is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.
  • Description
    Elinogrel is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PRT060128
  • Pathway
    GPCR/G Protein
  • Target
    P2Y Receptor
  • Recptor
    Na+/Ca2+ Exchanger
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    936500-94-6
  • Formula Weight
    523.94
  • Molecular Formula
    C20H15ClFN5O5S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (119.29 mM)
  • SMILES
    CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chiesi M, et al. Structural dependency of the inhibitory action of benzodiazepines and related compounds on the mitochondrial Na+-Ca2+ exchanger. Biochem Pharmacol. 1988 Nov 15;37(22):4399-403.
molnova catalog
related products
  • PPTN

    PPTN is a high-affinity, competitive and highly selective antagonist of P2Y14 receptor(KB value of 434 pM), with anti-inflammatory and immune activity.

  • PIT

    PIT (2,2'-Pyridylisatogen tosylate) is a specific, non-competitive antagonist of the Purinergic receptor P2Y1, exhibiting an IC50 of 0.14 μM for human P2Y1.

  • Clopidogrel thiolact...

    A thienopyridine-class antiplatelet agent that works by irreversibly inhibiting P2Y12 receptor on platelets.